You are viewing: Italy Pen Needles Market analysis
Part of: Pen Needles Market (Global)

The Italy Pen Needles Market was valued at $50.27 Million in 2024 and projected to reach to $75.76 Million by 2029, representing a compound annual growth rate of 7.1%. Italy's pen needles market is positioned for sustained growth driven by increasing diabetes prevalence and the shift toward self-administered injectable therapies.

Italy Pen Needles Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Italy Pen Needles Market Trends and Insights

  • This growth trajectory reflects Italy's increasing prevalence of diabetes and rising adoption of injectable therapies across the country.
  • Italy's healthcare infrastructure and reimbursement policies continue to support the adoption of advanced injection devices, positioning the market for sustained expansion through the forecast period. The Italian pen needles market benefits from a growing patient population requiring regular insulin and GLP-1 receptor agonist injections.
  • Italy's aging demographic and lifestyle factors have contributed to higher diabetes incidence, driving demand for convenient and user-friendly injection solutions.
  • Healthcare providers and patients in Italy increasingly recognize the clinical and quality-of-life benefits of pen needle technology, supporting market penetration across both urban and regional healthcare settings..

Key Market Statistics

  • CAGR (2024-2029) 7.1% CAGR
  • Market Size, 2024 ~USD 50.27 Million
  • Forecast, 2029 ~USD 75.76 Million
  • Country Italy

Italy Pen Needles Market Overview

Market Valuation :

Italy's pen needles market is valued at USD 50.27 million in 2024, with a projected CAGR of 7.1% through 2029, reaching USD 75.76 million by forecast end.

Diabetes Prevalence :

Rising diabetes incidence across Italy is driving demand for injectable therapies and pen needle adoption among both Type 1 and Type 2 diabetic patients.

Healthcare Infrastructure :

Italy's robust healthcare system and favorable reimbursement policies support widespread adoption of advanced injection devices and pen needle technologies.

Growth Trajectory :

With a 7.1% CAGR, Italy's market growth outpaces several European peers, reflecting strong patient compliance and physician preference for pen-based insulin delivery systems.

Italy Pen Needles Market Dynamics

  • The country's well-established healthcare infrastructure and supportive reimbursement frameworks create favorable conditions for market expansion.
  • Healthcare providers and pharmaceutical companies are investing in patient education and device accessibility, further accelerating adoption rates across Italian regions. Looking ahead to 2029, Italy's market is expected to benefit from technological advancements in needle design, improved patient comfort features, and expanded insurance coverage.
  • The aging population and lifestyle-related disease factors will continue to fuel demand.
  • Strategic partnerships between device manufacturers and Italian healthcare institutions will enhance distribution networks and market penetration, solidifying Italy's position as a key European market for pen needle solutions..

Market Ecosystem

logo-mobile

PEN NEEDLES MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
company logo
Develops a wide range of pen needles designed for insulin and GLP-1 delivery, including safety-engineered and ultra-fine variants compatible with multiple pen systems. Ensures precise dosage, minimizes needlestick injuries, and enhances patient comfort and adherence in diabetes management.
company logo
Manufactures high-quality pen needles optimized for its insulin pens and GLP-1 therapies, focusing on smooth penetration and ease of use. Improves injection comfort, ensures consistent insulin delivery, and promotes better self-management among diabetic patients.
company logo
Offers pen needles under the “Omnican” brand, designed for accurate insulin injection with ergonomic grip and minimal penetration force. Provides enhanced safety, precision, and comfort, reducing anxiety associated with daily injections.
company logo
Specializes in pen needles compatible with various injection pens and integrates user-friendly, low-pain technology for chronic disease management. Enhances user experience through ergonomic design, reliable connectivity with injection devices, and improved compliance.
company logo
Produces fine-gauge pen needles featuring advanced Japanese micro-needle technology for accurate and gentle drug delivery. Reduces injection pain, improves dosing precision, and supports patient confidence in self-injection therapy.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

Related Ecosystem

Drug Delivery Devices

Top Technologies
  • Disposable Autoinjectors
  • Reusable Autoinjectors
  • Insulin Pumps
  • Pen Injectors
  • Transdermal Patches
Top Companies
  • Novo nordisk a/s
  • Becton, Dickinson and Company
  • Terumo Corporation
  • Medtronic plc
  • Nipro Corporation

    Medical Devices

    Top Technologies
    • Polymerase Chain Reaction (PCR)
    • Magnetic Resonance Imaging (MRI)
    • Disposable Autoinjectors
    • Pulse Oximeters
    • Blood Pressure Monitors
    Top Companies
    • Medtronic plc
    • Abbott Laboratories
    • Stryker Corporation
    • Becton, Dickinson and Company
    • JOHNSON & JOHNSON

      Key Takeaways

      • Italy's pen needles market is valued at USD 50.27 million in 2024 and is forecast to reach USD 75.76 million by 2029, representing a 7.1% CAGR.
      • Rising diabetes prevalence and aging population in Italy are primary drivers of increased demand for injectable therapies and pen needle devices.
      • Italy's established healthcare reimbursement framework supports consistent adoption of pen needle technology across public and private healthcare sectors.
      • Growing patient preference for convenient, minimally invasive injection solutions in Italy is accelerating market expansion and product innovation.

      Pen Needles Market Report Scope

      Report Metric Details
      Base Year 2024
      Fastest Growing Segment SAFETY PEN NEEDLES (Type)
      Forecast Period 2024–2029
      Growth Rate CAGR of 9.2% from 2024 to 2029
      Largest Segment STANDARD PEN NEEDLES (Type)
      Market Size Base Year (Billions) ~USD 1.82 (2024)
      Revenue Forecast (Billions) ~USD 3.08 (2029)
      Segments Covered Type, Length, Application, Mode Of Purchase, Care Setting

      Italy Pen Needles Market Report Segmentation

      5 segment dimensions are covered across the global market.

      By Type

      • Safety Pen Needles
      • Standard Pen Needles

      By Length

      • 10Mm
      • 12Mm
      • 4Mm
      • 5Mm
      • 6Mm
      • 8Mm

      By Application

      • Glp-1 Therapy
      • Growth Hormone Therapy
      • Insulin Therapy
      • Osteoporosis
      • Other Applications

      By Mode Of Purchase

      • Online Purchase
      • Otc Purchase
      • Other Modes Of Purchase
      • Prescription-Based Purchase

      By Care Setting

      • Home Care Settings
      • Hospitals & Clinics
      • Hospitals And Clinics
      • Other End Users

      ITALY: PEN NEEDLES MARKET, BY APPLICATION, 2022–2030

      Segment20222023202420252026202820292030CAGR (%)
      GLP-1 THERAPY3.223.293.453.663.94.454.785.156.9
      GROWTH HORMONE THERAPY0.870.860.860.880.90.950.991.022.8
      INSULIN THERAPY43.8945.347.9351.3555.1564.1869.5875.77.9
      OSTEOPOROSIS2.532.582.692.843.013.413.643.916.4
      OTHER APPLICATIONS4.384.384.54.684.885.355.645.954.8
      TOTAL54.8956.4159.4463.4267.8478.3484.6291.737.5

      Target Audience

      • Medical Device Manufacturers : Manufacturers seeking to expand or establish operations in Italy need market-specific data on sizing, growth rates, competitive positioning, and regulatory requirements for pen needle products.
      • Healthcare Investors & PE Firms : Investment professionals evaluating opportunities in Italian healthcare require detailed market valuations, CAGR projections, and growth drivers to assess portfolio potential and ROI.
      • Pharmaceutical Companies : Pharma firms developing insulin and GLP-1 therapies need Italy-specific pen needle market data to optimize product bundling strategies and forecast injectable therapy adoption rates.
      • Healthcare Distributors & Retailers : Italian distributors and pharmacy chains require market intelligence on demand forecasts, product trends, and reimbursement policies to optimize inventory and procurement decisions.
      • Healthcare Policy & Government Bodies : Italian health authorities and policy makers use market data to inform healthcare budgeting, reimbursement policy development, and strategic planning for diabetes management programs.

      Key Companies in the Italy Pen Needles Market

      CompanyHQOwnershipStrongest segments
      KINDRED HEALTHCARE INC.United StatesPrivate CompanyInjectable and infusion-based delivery in LTAC hospitals,Oral drug administration in inpatient rehabilitation facilities,Contract rehabilitation and outpatient-related drug administration support,
      ATS AUTOMATION TOOLING SYSTEMS INCCanadaPublic CompanyTurnkey automated manufacturing and assembly systems,Lifecycle services and digital/connected factory solutions,Contract manufacturing and value-added integration,
      ALLERGAN PLCIrelandPrivate CompanyMedical Aesthetics & Dermatology,Eye Care,Neuroscience & CNS,
      CONSORT MEDICALUnited KingdomPrivate CompanyInhalation delivery devices,Injectable and autoinjector devices,Nasal and other specialty devices,
      HENRY SCHEINUnited StatesPublic CompanyGlobal Distribution & Value-Added Services,Global Specialty Products,Global Technology,
      EMBECTA CORP.United StatesPublic CompanyPen needles,Syringes,Safety injection devices,
      NOVO NORDISK A/SDenmarkPublic CompanyGLP-1 for Diabetes (injectable and oral),Obesity Care (GLP-1, including Wegovy pill),Insulin and Smart Pens (NovoPen 6, Echo Plus, needles),
      YPSOMEDSwitzerlandPublic CompanyPen injectors,Auto-injectors,Wearable injectors and patch pumps,
      TERUMO CORPORATIONJapanPublic CompanyCardiac and Vascular Company,Medical Care Solutions Company,Blood and Cell Technologies Company,
      NIPROJapanPublic CompanyDialysis products and artificial organ-related devices,Injection and infusion products, hospital and diabetic products,Pharmaceutical-related (generics, kits, CDMO for injectables and oral drugs),
      ARKRAY, INC.JapanPrivate CompanyDiabetes testing & blood glucose monitoring,Urinalysis,Immunodiagnostics,
      HTL-STREFAPolandPrivate CompanySafety lancets for professional capillary sampling,Personal lancets for home blood glucose monitoring,Pen needles for diabetes therapy,
      BERPU MEDICAL TECHNOLOGY CO., LTD.ChinaPrivate CompanyRegular insulin pen needles,Safety insulin pen needles and pens,Hypodermic and hypo-dermal needles,

      KINDRED HEALTHCARE INC.

      Kindred Healthcare Inc. is a United States-based private company founded in 1985 that operates with 64,200 employees. The company provides healthcare services and related solutions across the United States.

      ATS AUTOMATION TOOLING SYSTEMS INC

      ATS Automation Tooling Systems Inc. is a Canadian public company founded in 1978 with 7,000 employees. The company specializes in automation and tooling systems for industrial applications.

      ALLERGAN PLC

      Allergan PLC is an Ireland-based private company founded in 1983 with 17,400 employees. The company operates in the pharmaceutical and medical aesthetics sectors.

      CONSORT MEDICAL

      Consort Medical is a United Kingdom-based private company founded in 1938 with 2,000 employees. The company provides medical device and pharmaceutical delivery solutions.

      HENRY SCHEIN

      Henry Schein is a United States-based public company founded in 1932 with 25,000 employees. The company is a distributor of healthcare products and services to medical, dental, and veterinary professionals.

      EMBECTA CORP.

      Embecta Corp. is a United States-based public company founded in 1924 with 1,850 employees. The company manufactures and distributes diabetes care and medical devices.

      NOVO NORDISK A/S

      Novo Nordisk A/S is a Denmark-based public company founded in 1923 with 67,900 employees. The company is a global pharmaceutical company specializing in diabetes, obesity, and other chronic diseases.

      YPSOMED

      Ypsomed is a Switzerland-based public company founded in 1984 with 2,025 employees. The company develops and manufactures injection and infusion systems for diabetes and other therapeutic areas.

      TERUMO CORPORATION

      Terumo Corporation is a Japan-based public company founded in 1921 with 30,591 employees. The company manufactures and distributes medical devices, blood products, and pharmaceutical solutions globally.

      NIPRO

      Nipro is a Japan-based public company founded in 1947 with 38,593 employees. The company manufactures and supplies medical devices, pharmaceuticals, and healthcare products worldwide.

      ARKRAY, INC.

      Arkray, Inc. is a Japan-based private company founded in 1960 with 566 employees. The company manufactures diagnostic and medical devices for healthcare applications.

      HTL-STREFA

      HTL-Strefa is a Poland-based private company founded in 2000. The company manufactures medical devices and related healthcare products.

      BERPU MEDICAL TECHNOLOGY CO., LTD.

      Berpu Medical Technology Co., Ltd. is a China-based private company founded in 2000. The company manufactures medical devices and related healthcare solutions.

      Reasons to Buy this Report

      • Italy-Specific Market Sizing : Access precise valuation data for Italy's pen needles market with verified 2024 baseline (USD 50.27M) and 2029 forecasts, enabling accurate business planning and investment decisions.
      • Competitive Landscape Intelligence : Understand Italy's unique competitive dynamics, local manufacturer presence, and market share distribution specific to the Italian healthcare ecosystem and regulatory environment.
      • Reimbursement & Regulatory Insights : Gain detailed knowledge of Italy's healthcare reimbursement policies, regulatory pathways, and insurance coverage frameworks that directly impact market access and pricing strategies.
      • Regional Growth Drivers : Identify Italy-specific growth catalysts including diabetes prevalence rates, aging demographics, healthcare infrastructure investments, and patient adoption trends unique to Italian regions.
      • Strategic Market Entry Planning : Develop targeted go-to-market strategies for Italy with localized insights on distribution channels, healthcare provider preferences, and patient segments most receptive to pen needle solutions.

      Frequently asked questions

      What is the current size of Italy's pen needles market?

      Italy's pen needles market was valued at USD 50.27 million in 2024 and is expected to grow to USD 75.76 million by 2029.

      What is the projected growth rate for pen needles in Italy?

      Italy's pen needles market is projected to grow at a compound annual growth rate (CAGR) of 7.1% from 2024 to 2029.

      What factors are driving growth in Italy's pen needles market?

      Key drivers include rising diabetes prevalence, an aging population, increased adoption of injectable therapies, and strong healthcare reimbursement policies in Italy.

      How does Italy's pen needles market compare to other European countries?

      Italy represents a significant segment of the European pen needles market, with steady growth supported by its established healthcare infrastructure and patient base requiring injectable diabetes management.

      Which patient populations in Italy are driving pen needle demand?

      Patients with Type 1 and Type 2 diabetes requiring insulin therapy, as well as those using GLP-1 receptor agonists, represent the primary demand drivers in Italy's pen needles market.

      RESEARCH METHODOLOGY

      This research study involved the extensive use of both primary and secondary sources. It involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, the competitive landscape of market players, and key market dynamics such as drivers, opportunities, challenges, restraints, and key player strategies.

      Secondary Research

      This research study involved the wide use of secondary sources such as directories, databases such as D&B Hoovers, Bloomberg Businessweek, and Factiva; white papers; and companies’ house documents. Secondary research was undertaken to identify and collect information for this extensive, technical, market-oriented, and commercial study of the pen needles market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

      Primary Research

      In the primary research process, various supply-side and demand-side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, engineers, and related key executives from various companies and organizations operating in the pen needles market. Primary sources from the demand side included personnel from hospitals and clinics, researchers, lab technicians, purchase managers, and stakeholders from corporate & government bodies.

      A breakdown of the primary respondents for the pen needles market (supply side) market is provided below:

      Pen Needles Market
 Size, and Share

      Note 1: Companies are classified into tiers based on their total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.
      Note 2: C-level executives include CEOs, COOs, CTOs, and VPs.
      Note 3: Other primaries include sales managers, marketing managers, and product managers.

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      The market size for pen needles was determined using data from four different sources, which will be discussed below. Each method was evaluated, and a weighted average was calculated based on the number of assumptions made by each approach. The market size for pen needles was ultimately derived from these three distinct sources, as detailed in the following sections.

      Pen Needles Market: Bottom-up Approach & Top-down Approach

      Pen Needles Market Top Down and Bottom Up Approach

      Data Triangulation

      The entire market was divided into five segments to determine its size. Data triangulation and market breakdown processes were applied where necessary to complete the market engineering process and accurately arrive at the statistics for each segment.

      To estimate the market size and forecast growth, secondary data from both paid and unpaid sources were utilized. A thorough analysis of the sales of pen needles from major players helped establish their market rankings. Due to data limitations, the revenue share for certain companies was calculated based on an in-depth examination of their product portfolios and individual sales performance. This information was verified at each stage through detailed interviews with industry professionals.

      Market Definition

      A pen needle is a hollow needle fixed within a plastic hub and connected to injectable pens. These pen needles come in various lengths and diameters, making them suitable for use by both healthcare professionals and patients to administer injectable medications. They are electro-polished to ensure smooth, thin, and fine-point tips, which enhance comfort and ease during penetration. Pen needles offer a modern alternative for drug delivery compared to traditional injection methods.

      Key Stakeholders

      • Manufacturers of pen needles, insulin pens, injectable drug delivery devices, and diabetes supplies
      • Original equipment manufacturing companies
      • Suppliers and distributors of pen needles, insulin pens, injectable drug delivery devices, and diabetes supplies
      • Healthcare service providers
      • Teaching hospitals and academic medical centers
      • Health insurance players
      • Government bodies/municipal corporations
      • Regulatory bodies
      • Business research and consulting service providers
      • Authorities framing reimbursement policies for pen needles
      • Venture capitalists
      • Market research and consulting firms

      Report Objectives

      • To define, describe, and forecast the pen needles market based on type, length, application, mode of purchase, setting, and region.
      • To provide detailed information about the major factors influencing the market growth (such as drivers, restraints, challenges, and opportunities)
      • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall pen needles market
      • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
      • To forecast the size of the pen needles market in North America, Europe, the Asia Pacific, Latin America, Middle East & Africa, and GCC Countries
      • To profile the key players and comprehensively analyze their market shares and core competencies in the pen needles market
      • To track and analyze competitive developments such as partnerships, expansions, acquisitions, collaborations, product launches, agreements, and other developments in the pen needles market
      • To benchmark players within the pen needles market using the Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings.

      Available customizations:

      With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:

      Company Information

      • Detailed analysis and profiling of additional market players (up to 5)

      Geographic Analysis

      • Further breakdown of the Rest of Europe pen needles market into Denmark and Norway, among others
      • Further breakdown of the Rest of Asia Pacific pen needles market into countries such as Vietnam

       

      Get the Full Pen Needles Market Report

      Full forecast, segment splits, and company analysis for all Pen Needles Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status